BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:EYU688 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of EYU688\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06006559-11254@assetmemo.bio
DTSTAMP:20261121T004104Z
DTSTART;VALUE=DATE:20270722
DTEND;VALUE=DATE:20270723
SUMMARY:EYU688: Phase 2 readout est. (NCT06006559)
DESCRIPTION:EYU688\, phase 2\, Dengue.\nStudy: A Study to Assess the Effica
 cy\, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever\n
 Estimated primary completion: 22 July 2027. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/eyu688#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT06006559
URL:https://assetmemo.bio/drug/eyu688#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
